Literature DB >> 9463379

IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.

A M O'Farrell1, Y Liu, K W Moore, A L Mui.   

Abstract

Interleukin-10 (IL-10) limits inflammatory responses by inhibiting macrophage activation. In macrophages, IL-10 activates Stat1 and Stat3. We characterized IL-10 responses of the J774 mouse macrophage cell line, and of J774 cells expressing wild-type hIL-10R, mutant hIL-10R lacking two membrane-distal tyrosines involved in recruitment of Stat3 (hIL-10R-TyrFF), a truncated Stat3 (DeltaStat3) which acts as a dominant negative, or an inducibly active Stat3-gyraseB chimera (Stat3-GyrB). A neutralizing anti-mIL-10R monoclonal antibody was generated to block the function of endogenous mIL-10R. IL-10 inhibited proliferation of J774 cells and of normal bone marrow-derived macrophages, but not J774 cells expressing hIL-10RTyrFF. Dimerization of Stat3-GyrB by coumermycin mimicked the effect of IL-10, and expression of DeltaStat3 blocked the anti-proliferative activity of IL-10. For macrophage de-activation responses, hIL10R-TyrFF could not mediate inhibition of lipopolysaccharide-induced TNFalpha, IL-1beta or CD86 expression, while DeltaStat3 did not interfere detectably with these IL-10 responses. Thus signals mediating both anti-proliferative and macrophage de-activation responses to IL-10 require the two membrane-distal tyrosines of IL-10R, but Stat3 appears to function only in the anti-proliferative response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9463379      PMCID: PMC1170450          DOI: 10.1093/emboj/17.4.1006

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  67 in total

1.  The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor.

Authors:  Y Liu; R de Waal Malefyt; F Briere; C Parham; J M Bridon; J Banchereau; K W Moore; J Xu
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

2.  Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release.

Authors:  L Oehler; M Foedinger; M Koeller; M Kollars; E Reiter; B Bohle; S Skoupy; G Fritsch; K Lechner; K Geissler
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

3.  Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation.

Authors:  D P Ascherman; T S Migone; M C Friedmann; W J Leonard
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

Review 4.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

5.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6.

Authors:  Z Zhong; Z Wen; J E Darnell
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

6.  Expression cloning and characterization of a human IL-10 receptor.

Authors:  Y Liu; S H Wei; A S Ho; R de Waal Malefyt; K W Moore
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

7.  A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses.

Authors:  A E Chernoff; E V Granowitz; L Shapiro; E Vannier; G Lonnemann; J B Angel; J S Kennedy; A R Rabson; S M Wolff; C A Dinarello
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

8.  Role of endogenous interferon-beta in lipopolysaccharide-triggered activation of the inducible nitric-oxide synthase gene in a mouse macrophage cell line, J774.

Authors:  M Fujihara; N Ito; J L Pace; Y Watanabe; S W Russell; T Suzuki
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

9.  Possible mechanisms accounting for the growth factor independence of hematopoietic progenitors from umbilical cord blood.

Authors:  K R Schibler; Y Li; R K Ohls; N C Nye; M C Durham; W White; K W Liechty; T Le; R D Christensen
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

10.  Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs.

Authors:  A L Mui; H Wakao; A M O'Farrell; N Harada; A Miyajima
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

View more
  132 in total

1.  Regulatory function of in vivo anergized CD4(+) T cells.

Authors:  K Jooss; B Gjata; O Danos; H von Boehmer; A Sarukhan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.

Authors:  Ling-Yuan Kong; Adam S Wu; Tiffany Doucette; Jun Wei; Waldemar Priebe; Gregory N Fuller; Wei Qiao; Raymond Sawaya; Ganesh Rao; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2010-10-04       Impact factor: 12.531

Review 3.  A potential role of ruxolitinib in leukemia.

Authors:  Kiran Naqvi; Srdan Verstovsek; Hagop Kantarjian; Farhad Ravandi
Journal:  Expert Opin Investig Drugs       Date:  2011-06-03       Impact factor: 6.206

4.  Critical requirement for Stat5 in a mouse model of polycythemia vera.

Authors:  Dongqing Yan; Robert E Hutchison; Golam Mohi
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

5.  CCAAT/enhancer binding protein-δ expression by dendritic cells regulates CNS autoimmune inflammatory disease.

Authors:  Vicky W W Tsai; Mohammad G Mohammad; Ornella Tolhurst; Samuel N Breit; Paul E Sawchenko; David A Brown
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

6.  Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection.

Authors:  Vishal Sindhava; Michael E Woodman; Brian Stevenson; Subbarao Bondada
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

Review 7.  Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?

Authors:  Amy B Heimberger; John H Sampson
Journal:  Neuro Oncol       Date:  2010-12-10       Impact factor: 12.300

8.  Salmonella pathogenicity island 2-dependent expression of suppressor of cytokine signaling 3 in macrophages.

Authors:  Kei-Ichi Uchiya; Toshiaki Nikai
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

9.  Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples.

Authors:  Jinquan Cai; Qun Chen; Yuqiong Cui; Jiawei Dong; Meng Chen; Pengfei Wu; Chuanlu Jiang
Journal:  Oncoimmunology       Date:  2018-02-13       Impact factor: 8.110

10.  Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes.

Authors:  Aroonwan Lam-ubol; Dustin Hopkin; Elena M Letuchy; Zoya B Kurago
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.